GBBWRPM
BIIB icon

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Biogen BIIB Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-203
Closed -$59K – 118
2018
Q2 		$59K Hold
203
– – 0.02% 161
2018
Q1 		$56K Hold
203
– – 0.02% 160
2017
Q4 		$71K Buy
203
+155
+323% +$49.7K 0.19% 82
2017
Q3 		$15K Hold
48
– – 0.01% 250
2017
Q2 		$13K Sell
48
-62
-56% -$16.4K 0.01% 256
2017
Q1 		$31K Buy
110
+62
+129% +$17.5K 0.01% 186
2016
Q4 		$14K Sell
48
-157
-77% -$46.5K ﹤0.01% 288
2016
Q3 		$64K Hold
205
– – 0.03% 137
2016
Q2 		$49K Hold
205
– – 0.02% 146
2016
Q1 		$53K Hold
205
– – 0.03% 128
2015
Q4 		$63K Buy
+205
New +$58.9K 0.03% 109

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's BIIB Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Biogen (BIIB) in Q3 2018, closing a stake of 203 shares — an estimated $59K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in BIIB in Q4 2015 and held it in 11 quarters. The position peaked at $71K in Q4 2017. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 203 Biogen shares in Q3 2018, an estimated $59K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Biogen in Q4 2015 and held it in 11 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Biogen position peaked at $71K in Q4 2017.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.